This announcement is a separate document:
南京证券股份有限公司关于江苏诺泰澳赛诺生物制药股份有限公司首次公开发行部分限售股上市流通的核查意见
Nanjing Securities Co., Ltd.'s inspection opinion on the initial public offering of some restricted shares of Jiangsu Nuotai Aosainuo Biopharmaceutical Co., Ltd. on the listing and circulation of some restricted shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.